13 research outputs found
Complete remission in the nephrotic syndrome study network
Background and objectives This analysis from the Nephrotic Syndrome Study Network (NEPTUNE) assessed the phenotypic and pathology characteristics of proteinuric patients undergoing kidney biopsy and defined the frequency and factors associated with complete proteinuria remission (CRever). Design, setting, participants, & measurements We enrolled adults and children with proteinuria β₯0.5 g/d at the time of first clinically indicated renal biopsy at 21 sites in North America from April 2010 to June 2014 into a prospective cohort study. NEPTUNE central pathologists assigned participants to minimal-change disease (MCD), FSGS, membranous nephropathy, or other glomerulopathy cohorts. Outcome measures for this analysis were (1) CRever with urine protein-to-creatinine ratio (UPC)<0.3 g/g with preserved native kidney function and (2) ESRD. Continuous variables are reported as median and interquartile range (IQR; 25th, 75th percentile). Cox proportional hazards modeling was used to assess factors associated with CRever. Results We enrolled 441 patients: 116 (27%) had MCD, 142 (32%) had FSGS, 66 (15%) had membranous nephropathy, and 117 (27%) had other glomerulopathy. The baseline UPC was 4.1 g/g (IQR, 1.9, 7.7) and the eGFR was 81 ml/min per 1.73 m2 (IQR, 50, 105). Median duration of observation was 19 months (IQR, 11, 30). CRever occurred in 46% of patients, and 4.6% progressed to ESRD. Multivariate analysis demonstrated that higher prebiopsy proteinuria (hazard ratio, 0.3; 95% confidence interval, 0.2 to 0.5) and pathology diagnosis (FSGS versus MCD; hazard ratio, 0.2; 95% confidence interval, 0.1 to 0.5) were inversely associated with CRever. The effect of immunosuppressive therapy on remission varied by pathology diagnosis. Conclusions In NEPTUNE, the high frequency of other pathology in proteinuric patients affirms the value of the diagnostic kidney biopsy. Clinical factors, including level of proteinuria before biopsy, pathology diagnosis, and immunosuppression, are associated with complete remission
The Invasion of the American Rotifer Kellicottia bostoniensis (Rousselet, 1908) (Rotifera: Brachionidae) into Vygozersky Reservoir (Republic of Karelia, Russia)
New Information on the Findings of Alien Rotifer Kellicottia bostoniensis (Rousselet, 1908) (Rotifera: Monogononta: Brachionidae) in Nizhny Novgorod Oblast
American rotifer Kellicottia bostoniensis (Rousselet, 1908) (Rotifera: Brachionidae) in the Kama Reservoir (Kama River, Russia)
Distribution of rotifer Kellicottia bostoniensis (Rousselet, 1908) (Rotifera: Brachionidae) in water bodies and watercourses of Nizhny Novgorod oblast
ΠΠ΅ΠΉΡΠΎΡΠ½Π΄ΠΎΠΊΡΠΈΠ½Π½Π°Ρ Π³ΠΈΠΏΠ΅ΡΠΏΠ»Π°Π·ΠΈΡ ΠΌΠ»Π°Π΄Π΅Π½ΡΠ΅Π²: ΠΎΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ ΠΈ ΡΠ΅ΡΠΈΡ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠΉ
Neuroendocrine hyperplasia of infancy (NEHI) is a rare disease of unknown etiology, which is observed in children of the first 2 years of life, characterized by persistent tachypnea syndrome and such nonspecific changes in lung biopsy as hyperplasia of bombesin-positive neuroendocrine cells of the peripheral respiratory tract. The article provides data on pathogenesis, clinical, morphological and image-diagnostics of this rare lung disease. It also presents data on observations of 26 patients with NEHI.ΠΠ΅ΠΉΡΠΎΡΠ½Π΄ΠΎΠΊΡΠΈΠ½Π½Π°Ρ Π³ΠΈΠΏΠ΅ΡΠΏΠ»Π°Π·ΠΈΡ ΠΌΠ»Π°Π΄Π΅Π½ΡΠ΅Π² (ΠΠΠΠ) - ΡΠ΅Π΄ΠΊΠΎΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅ Π½Π΅ΠΈΠ·Π²Π΅ΡΡΠ½ΠΎΠΉ ΡΡΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ, Π½Π°Π±Π»ΡΠ΄Π°ΡΡΠ΅Π΅ΡΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΏΠ΅ΡΠ²ΡΡ
2 Π»Π΅Ρ ΠΆΠΈΠ·Π½ΠΈ, Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΡΡΠ΅Π΅ΡΡ Π½Π°Π»ΠΈΡΠΈΠ΅ΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° ΠΏΠ΅ΡΡΠΈΡΡΠΈΡΡΡΡΠ΅Π³ΠΎ ΡΠ°Ρ
ΠΈΠΏΠ½ΠΎΡ ΠΈ Π½Π΅ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ ΠΏΡΠΈ Π±ΠΈΠΎΠΏΡΠΈΠΈ Π»Π΅Π³ΠΊΠΈΡ
Π² Π²ΠΈΠ΄Π΅ Π³ΠΈΠΏΠ΅ΡΠΏΠ»Π°Π·ΠΈΠΈ Π±ΠΎΠΌΠ±Π΅Π·ΠΈΠ½-ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½ΡΡ
Π½Π΅ΠΉΡΠΎΡΠ½Π΄ΠΎΠΊΡΠΈΠ½Π½ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π΄ΡΡ
Π°ΡΠ΅Π»ΡΠ½ΡΡ
ΠΏΡΡΠ΅ΠΉ. ΠΡΠΈΠ²Π΅Π΄Π΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ ΠΎ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π΅, ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ, ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈ ΠΈΠΌΠΈΠ΄ΠΆ-Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ Π΄Π°Π½Π½ΠΎΠ³ΠΎ ΡΠ΅Π΄ΠΊΠΎΠ³ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π»Π΅Π³ΠΊΠΈΡ
. Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ ΠΎ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡΡ
Π·Π° 26 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌΠΈ Ρ ΠΠΠΠ
ΠΠ΅ΠΉΡΠΎΡΠ½Π΄ΠΎΠΊΡΠΈΠ½Π½Π°Ρ Π³ΠΈΠΏΠ΅ΡΠΏΠ»Π°Π·ΠΈΡ ΠΌΠ»Π°Π΄Π΅Π½ΡΠ΅Π²: ΠΎΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ ΠΈ ΡΠ΅ΡΠΈΡ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠΉ
Neuroendocrine hyperplasia of infancy (NEHI) is a rare disease of unknown etiology, which is observed in children of the first 2 years of life, characterized by persistent tachypnea syndrome and such nonspecific changes in lung biopsy as hyperplasia of bombesin-positive neuroendocrine cells of the peripheral respiratory tract. The article provides data on pathogenesis, clinical, morphological and image-diagnostics of this rare lung disease. It also presents data on observations of 26 patients with NEHI.ΠΠ΅ΠΉΡΠΎΡΠ½Π΄ΠΎΠΊΡΠΈΠ½Π½Π°Ρ Π³ΠΈΠΏΠ΅ΡΠΏΠ»Π°Π·ΠΈΡ ΠΌΠ»Π°Π΄Π΅Π½ΡΠ΅Π² (ΠΠΠΠ) - ΡΠ΅Π΄ΠΊΠΎΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅ Π½Π΅ΠΈΠ·Π²Π΅ΡΡΠ½ΠΎΠΉ ΡΡΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ, Π½Π°Π±Π»ΡΠ΄Π°ΡΡΠ΅Π΅ΡΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΏΠ΅ΡΠ²ΡΡ
2 Π»Π΅Ρ ΠΆΠΈΠ·Π½ΠΈ, Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΡΡΠ΅Π΅ΡΡ Π½Π°Π»ΠΈΡΠΈΠ΅ΠΌ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° ΠΏΠ΅ΡΡΠΈΡΡΠΈΡΡΡΡΠ΅Π³ΠΎ ΡΠ°Ρ
ΠΈΠΏΠ½ΠΎΡ ΠΈ Π½Π΅ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ ΠΏΡΠΈ Π±ΠΈΠΎΠΏΡΠΈΠΈ Π»Π΅Π³ΠΊΠΈΡ
Π² Π²ΠΈΠ΄Π΅ Π³ΠΈΠΏΠ΅ΡΠΏΠ»Π°Π·ΠΈΠΈ Π±ΠΎΠΌΠ±Π΅Π·ΠΈΠ½-ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½ΡΡ
Π½Π΅ΠΉΡΠΎΡΠ½Π΄ΠΎΠΊΡΠΈΠ½Π½ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π΄ΡΡ
Π°ΡΠ΅Π»ΡΠ½ΡΡ
ΠΏΡΡΠ΅ΠΉ. ΠΡΠΈΠ²Π΅Π΄Π΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ ΠΎ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π΅, ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ, ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈ ΠΈΠΌΠΈΠ΄ΠΆ-Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ Π΄Π°Π½Π½ΠΎΠ³ΠΎ ΡΠ΅Π΄ΠΊΠΎΠ³ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π»Π΅Π³ΠΊΠΈΡ
. Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ ΠΎ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡΡ
Π·Π° 26 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌΠΈ Ρ ΠΠΠΠ